undamentalytics Newsletter
Sign in

Pavmed Inc. key statistics and ratios

In fiscal 2025, Pavmed Inc. had return on equity of 2.5%, an operating margin of -30712.7%, debt equal to 23.1% of equity and a current ratio of 0.17. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Gross margin−17.0%——−61.3%——
Operating margin<−999%<−999%<−999%<−999%<−999%<−999%
Net margin<−999%<−999%<−999%>999%564.8%<−999%
Free-cash-flow margin<−999%<−999%<−999%<−999%<−999%<−999%
Return on equity−81.6%———2.5%−35.0%
Return on assets−57.9%−126.3%−147.4%124.8%1.2%−30.6%
Asset turnover0.010.010.060.090.000.00
Current ratio10.931.070.450.060.171.19
Debt to equity0.0%———23.1%43.1%
Interest cover (operating income ÷ interest)—n/mn/mn/mn/mn/m
Effective tax rate———0.0%——
R&D as % of revenue>999%>999%571.0%197.7%>999%>999%
Capital spending as % of revenue293.8%408.5%9.7%1.8%43.7%46.4%
Free cash flow ÷ net income———−84.5%<−999%—

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

1 of 3 checks passed · June 30, 2026
What it owns · $40m
Short-term assets $5mLonger-term assets $35m
What it owes, and who funded it · $56m
Short-term liabilities $4mLonger-term liabilities $17mShareholders' equity $35m
  • Short-term assets cover short-term liabilities $5m of assets due within a year against $4m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $5m short-term assets against $17m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Operating income of −$27m against $8,000 of interest.

From Pavmed Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

20 /100

Weak moat

How hard Pavmed's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median -127.3% of total assets over 10 years.

  • Pricing power 0 / 20

    Gross margin has been a median -74.9%, moving by 218.4 percentage points (standard deviation) across 5 years.

  • Durability 10 / 20

    Operating margin has been a median -9686.4%; its worst year was -23842.9%.

  • Cash conversion 0 / 20

    Free cash flow was positive in 0 of 5 years, at a median -6948.2% of revenue.

  • Discipline 10 / 20

    The diluted share count fell 94.5% over five years; stock-based pay has been a median 1530.4% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: PAVM vs POASNXL vs PAVMPAVM vs QTEXCUPR vs PAVM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Pavmed Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pavmed Inc.